CommercialAdministrativeLow impact
07.11.02f, Measurement of Exhaled Nitric Oxide and Breath Condensate in the Diagnosis and Management of Asthma and Other Respiratory Disorders
Independence Blue Cross·PA · Pulmonology, Internal Medicine, Pediatrics +1 more·Medical Policy
We identified it
Jun 25, 2026
Summary
This is a routine annual reissue of Independence Blue Cross policy 07.11.02f with no substantive changes to coverage. Exhaled nitric oxide (CPT 95012) remains covered for asthma diagnosis and management up to 5 tests per 12-month period, while exhaled breath condensate (CPT 83987) remains non-covered as experimental/investigational. No billing workflow changes are required.
Action Required
No immediate action required. This is a routine annual policy reissue with no coverage changes. Billing team should verify that current billing rules continue to reflect: (1) CPT 95012 (exhaled nitric oxide) is covered for asthma diagnosis/management with a 5-test-per-12-months limit, and (2) CPT 83987 (exhaled breath condensate) remains denied as experimental/investigational. No system updates or documentation changes are needed.